Every year on April 25, the global scientific community pauses to recognize DNA Day, a date that marks the monumental publication of the double-helix structure in 1953 and the triumphant completion of the Human Genome Project in 2003. For the researchers at The Institute of Cancer Research (ICR),
Psychiatry’s most stubborn blind spot—objective tests that match the precision of cardiology or oncology—met a serious contender that stitched brain imaging, electrical rhythms, gut microbes, blood chemistry, and lived behavior into one accountable operating system for care. The technology under
Ivan Kairatov is a biopharma and health-tech veteran who has spent years turning clinical logic into usable digital tools. In this conversation, he explains how a new self-triage chatbot grounds every step in established medical flowcharts, why a multi-agent design matters, and where real-world
For a disease that quietly affects nearly half a million Americans each year, a precision antibiotic that erases Borrelia burgdorferi while leaving the microbiome intact would shift Lyme treatment from blunt-force regimens to targeted, durable care that preserves health far beyond the infection
Missed by the very blood tests meant to reveal them, too many testicular cancers slip through diagnostic nets just when speed matters most for adolescents and young adults facing life-shaping treatment choices. That gap is precisely what a new high-dimensional immune profiling approach set out to
Hospitals feel the squeeze as drug-resistant infections outpace discovery, while conventional screening drains time and money without delivering medicines that dissolve, distribute, and survive the real world. That pressure has pushed researchers to reimagine how drugs are created, trading
